Sarepta CEO: We’re ‘pretty brilliant’
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Morning! Today, a handful of STAT reporters pore through former President Trump’s own remarks over the past year or so to get a sense of his health care agenda. Also, we learn the new priority in CRISPR therapies is delivery, and more.
Read Original Article: Sarepta CEO: We’re ‘pretty brilliant’ »
